Human MYO1G protein (Recombinant) (N-His) (STJP003121)

SKU:
STJP003121
£328.50 - £1,437.50
Free Shipping
Processing The item has been added

Host: E. coli
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description : Recombinant-Human MYO1G-N-His protein was developed from e. coli and has a target region of N-His. For use in research applications.
Formulation: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Storage Instruction: Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at-20 to-80°C for twelve months from the date of receipt.
Gene Symbol: MYO1G
Gene ID: 64005
Uniprot ID: MYO1G_HUMAN
Immunogen Region: Gly769-Pro1016
Immunogen: Homo sapiens (Human)
Function Unconventional myosin required during immune response for detection of rare antigen-presenting cells by regulating T-cell migration. Unconventional myosins are actin-based motor molecules with ATPase activity and serve in intracellular movements. Acts as a regulator of T-cell migration by generating membrane tension, enforcing cell-intrinsic meandering search, thereby enhancing detection of rare antigens during lymph-node surveillance, enabling pathogen eradication. Also required in B-cells, where it regulates different membrane/cytoskeleton-dependent processes. Involved in Fc-gamma receptor (Fc-gamma-R) phagocytosis. Minor histocompatibility antigen HA-2: Constitutes the minor histocompatibility antigen HA-2. More generally, minor histocompatibility antigens (mHags) refer to immunogenic peptide which, when complexed with MHC, can generate an immune response after recognition by specific T-cells. The peptides are derived from polymorphic intracellular proteins, which are cleaved by normal pathways of antigen processing. The binding of these peptides to MHC class I or class II molecules and their expression on the cell surface can stimulate T-cell responses and thereby trigger graft rejection or graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation from HLA-identical sibling donor. GVHD is a frequent complication after bone marrow transplantation (BMT), due to mismatch of minor histocompatibility antigen in HLA-matched sibling marrow transplants. HA-2 is restricted to MHC class I HLA-A*0201.
Protein Name Unconventional Myosin-Ig Cleaved Into - Minor Histocompatibility Antigen Ha-2
Mhag Ha-2
Cellular Localisation Cell Membrane
Peripheral Membrane Protein
Cell Projection
Phagocytic Cup
Recruited To Fc-Gamma Receptor (Fc-Gamma-R) Phagocytic Cup
In T-Cells
Transiently Accumulates In Discrete Areas At The Plasma Membrane Of Migrating Cells Or When Membranes Are Deformed
Localization At The Membrane Is Not Highly Dependent On Phosphatidylinositol 4
5-Bisphosphate Levels
Released From The Membrane In The Presence Of Atp
May Be Enriched In Peripheral Processes
Such As Microvilli Or Ruffles
Alternative Protein Names Unconventional Myosin-Ig Cleaved Into - Minor Histocompatibility Antigen Ha-2 protein
Mhag Ha-2 protein
MYO1G protein
HA2 protein

Information sourced from Uniprot.org